In lung cancer, Wang et al. showed that tumor-initiating cells, the presumably most relevant cell type to target within the tumor bulk, possess high MAT2A-driven methionine cycle activity, leading to epigenetic changes and tumor initiation [51]. The gene discussed is MAT2A; the disease is lung cancer.